Track the Carl Zeiss Meditec AG stock price and the full directors' dealings record of the company, a listed issuer based in Germany. Shares are quoted on the DE market, under the oversight of BaFin. Operating in the Health Care sector, Carl Zeiss Meditec AG has published 3 insider filings. Market capitalisation: €2.8bn. The latest transaction was disclosed on 10 September 2026 (Buy). Among the most active insiders: Pecher, Andreas. The full history is openly available.
Analysts rate Carl Zeiss Meditec AG Hold (neutral), based on 14 analysts. Average price target: €27.24.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Carl Zeiss Meditec AG is a company specializing in medical technology, providing innovative solutions for the diagnosis and treatment of eye diseases. It is listed on the Frankfurt Stock Exchange (XETR).